Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
Cyclophilin D Chemical Structure
BCP28725 Cyclophilin D CypD
Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia.
Lampalizumab Chemical Structure
BCP23876 Lampalizumab 1278466-20-8
Lampalizumab is a potential therapeutic that targets complement factor D, a pivotal activator of the alternative complement pathway.
Clivatuzumab Chemical Structure
BCP49072 Clivatuzumab 1622075-09-5
Clivatuzumab is a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma.
Imdevimab Chemical Structure
BCP48954 Imdevimab 2415933-40-1
Imdevimab is a fully human monoclonal antibody against the surface spike protein of SARS-CoV-2.
Varokibart Chemical Structure
BCP48953 Varokibart 2643349-04-4
Varokibart is an IgG4λ, fully human anti-IL-5 monoclonal antibody that was developed for potential anti-inflammatory action.
Delpacibart etedesiran Chemical Structure
BCP48952 Delpacibart etedesiran 2653183-68-5
Delpacibart etedesiran is an immunoglobulin G1-kappa, anti-[Homo sapiens TFRC (transferrin receptor, TfR1)], humanized monoclonal antibody; conjugated via a 4-(maleimidomethyl)cyclohexanecarboxamide (MCC) linker with a double-stranded small interfering RNA (siRNA) which causes cleavage of the mRNA that encodes myotonin-protein kinase (MTPK, myotonic dystrophy 1 protein kinase, DM1 protein kinase, DMPK, DM-kinase, DMK, EC:
Vilobelimab Chemical Structure
BCP48950 Vilobelimab 2250440-41-4
Vilobelimab, an anti-C5a monoclonal antibody, was shown to be safe in a phase 2 trial of invasively mechanically ventilated patients with COVID-19.
TIM-3 antibody Chemical Structure
BCP25682 TIM-3 antibody Tim-3
TIM-3 (T cell Immunoglobulin and Mucin domain-3) is a 60 kDa member of the TIM family of immune regulating molecules.
Inotuzumab Chemical Structure
BCP47871 Inotuzumab 1660159-36-3
Inotuzumab is an antibody-drug conjugate, a type of drug in which an anticancer drug is chemically linked to another molecule that helps target the drug to cancer cells.
Burosumab Chemical Structure
BCP47491 Burosumab 1610833-03-8
Burosumab, a fully human monoclonal antibody to FGF23, is the only approved treatment for X-linked hypophosphatemia (XLH), a rare genetic disorder characterized by renal phosphate wasting and substantial cumulative musculoskeletal morbidity.
123下一页末页共 845 条记录 1 / 85 页